BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30188229)

  • 21. Tuberculosis in Poland in 2013.
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2015; 69(2):277-82, 389-93. PubMed ID: 26233087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
    Ong DM; Farrugia H; Wei A
    Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extrapulmonary tuberculosis in Poland in the years 1974-2010].
    Rowińska-Zakrzewska E; Korzeniewska-Koseła M; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2013; 81(2):121-9. PubMed ID: 23420428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cutaneous extramedullary hematopoiesis associated with myelodysplastic/myeloproliferative neoplasm, unclassifiable].
    Yoshida M; Horiuchi M; Ueda H; Hagihara K; Kanashima H; Nakao T; Hirata C; Inoue T; Yamane T
    Rinsho Ketsueki; 2015 Jul; 56(7):911-4. PubMed ID: 26256930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Race and nativity are major determinants of tuberculosis in the U.S.: evidence of health disparities in tuberculosis incidence in Michigan, 2004-2012.
    Noppert GA; Wilson ML; Clarke P; Ye W; Davidson P; Yang Z
    BMC Public Health; 2017 Jun; 17(1):538. PubMed ID: 28578689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Incidence of haematological neoplasms in Castilla y León, Spain].
    Rodríguez-García JA; Vázquez L; Ramos F; Cuevas B; Martín A; Smucler A; Guerola DN; Cantalapiedra A; Alonso JM; Fernández S; Díez E; Rodríguez MJ; Calmuntia MJ; Aguilar C; Sierra M; Gracia JA; Cebeira MJ; Cantalejo R;
    Med Clin (Barc); 2015 Jun; 144(11):491-500. PubMed ID: 25015251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting diagnostic criteria for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Borderline cases without anemia exist.
    Li P; Shahmarvand N; Lynch D; Gotlib JR; Merker JD; Zehnder JL; George TI; Ohgami RS
    Int J Lab Hematol; 2019 Jun; 41(3):345-352. PubMed ID: 30811101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coverage and accuracy of myeloproliferative and myelodysplastic neoplasms in the Finnish Cancer Registry.
    Leinonen MK; Rantanen M; Pitkäniemi J; Malila N
    Acta Oncol; 2016 Jun; 55(6):782-6. PubMed ID: 26767306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contact investigation for tuberculosis in Taiwan contacts aged under 20 years in 2005.
    Ling DL; Liaw YP; Lee CY; Lo HY; Yang HL; Chan PC
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):50-5. PubMed ID: 21276296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.
    Aul C; Gattermann N; Schneider W
    Br J Haematol; 1992 Oct; 82(2):358-67. PubMed ID: 1419819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?
    Padron E
    Hematology Am Soc Hematol Educ Program; 2015; 2015():349-54. PubMed ID: 26637742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Domestic impact of tuberculosis screening among new immigrants to Ontario, Canada.
    Khan K; Hirji MM; Miniota J; Hu W; Wang J; Gardam M; Rawal S; Ellis E; Chan A; Creatore MI; Rea E
    CMAJ; 2015 Nov; 187(16):E473-E481. PubMed ID: 26416993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis notifications in Australia, 2004.
    Roche PW; Antic R; Bastian I; Brown L; Christensen A; Hurwitz M; Konstantinos A; Krause VL; McKinnon M; Misrachi A; Waring J; ;
    Commun Dis Intell Q Rep; 2006; 30(1):93-101. PubMed ID: 16637237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis in Poland in 2017.
    Korzeniewska- Koseła M
    Przegl Epidemiol; 2019; 73(2):211-226. PubMed ID: 31385679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms.
    Ragon BK; Savona MR
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S37-S42. PubMed ID: 28760301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis in California dialysis patients.
    Ahmed AT; Karter AJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):341-5. PubMed ID: 15139473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
    Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
    JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nosocomial infection in adult admissions with hematological malignancies originating from different lineages: a prospective observational study.
    Liu H; Zhao J; Xing Y; Li M; Du M; Suo J; Liu Y
    PLoS One; 2014; 9(11):e113506. PubMed ID: 25415334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cumulative incidence of tuberculosis in lung cancer patients in Japan: A 6-year observational study.
    Suzuki Y; Imokawa S; Sato J; Uto T; Suda T
    Respir Investig; 2016 May; 54(3):179-83. PubMed ID: 27108013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of cataract for people with tuberculosis: results from a population-based cohort study.
    Hsia NY; Ho YH; Shen TC; Lin CL; Huang KY; Chen CH; Tu CY; Shih CM; Hsu WH; Sung FC
    Int J Tuberc Lung Dis; 2015 Mar; 19(3):305-11. PubMed ID: 25686139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.